Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

Clinical Pharmacology & TherapeuticsVolume 69, Issue 3 p. 89-95 Commentary Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework Biomarkers Definitions Working Group, Biomarkers Definitions Working GroupSearch for more papers by this author Biomarkers Definitions Working Group, Biomarkers Definitions Working GroupSearch for more papers by this author First published: 18 March 2001 https://doi.org/10.1067/mcp.2001.113989Citations: 522 Portions of this article were previously published as a conference proceedings report: Downing GJ, editor. Biomarkers and surrogate endpoints: clinical research and applications. Amsterdam: Elsevier Scientific; 2000. p. 1–7. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume69, Issue3March 2001Pages 89-95 RelatedInformation